Related Experiment Videos
[Immunity against tetanus in childhood]
G Cilla Eguiluz1, J R Sáenz Domínguez, M Urbieta Egaña
1Servicio de Microbiología, Hospital Ntra. Sra. de Aránzazu, San Sebastián.
Anales Espanoles De Pediatria
|June 1, 1993
Summary
Tetanus vaccination programs show excellent immunization coverage in children and adolescents, with high levels of protective antibodies. However, protection wanes in individuals beyond the adolescent period.
Area of Science:
- Immunology
- Vaccinology
- Public Health
Context:
- Evaluating the effectiveness of tetanus vaccination programs in a specific region.
- Assessing antibody levels in pediatric and adolescent populations.
Purpose:
- To determine the prevalence of protective tetanus antitoxin antibodies in children and adolescents.
- To evaluate the efficacy of current tetanus immunization strategies.
Summary:
- A study utilizing passive hemagglutination and toxin-neutralization assays found 93.2% of 591 children and adolescents had protective tetanus antitoxin antibody levels (≥0.01 IU/ml).
- Younger children (1-5 years) exhibited higher protection rates (97.5%) compared to older adolescents (16-19 years, 79.2%).
- Antibody titers peaked in the 6-10 year age group, aligning with booster vaccination schedules, with no significant sex-based differences in protection.
Impact:
- Demonstrates high tetanus vaccine effectiveness and excellent immunization coverage in the pediatric population.
- Highlights a decline in protection among individuals post-adolescence, suggesting potential gaps in long-term immunity.
- Provides evidence for successful public health interventions in controlling tetanus within younger demographics.